Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,5209 USD | +2,12% | +0,95% | -4,12% |
22/03 | Sangamo Therapeutics prijst $24 miljoen Geregistreerd Direct Aanbod | MT |
14/03 | Sangamo Therapeutics duwt neurologieprogramma's richting klinische ontwikkeling, zegt Wedbush | MT |
Omzet 2024 * | 36,94 mln. 34,5 mln. | Omzet 2025 * | 64,14 mln. 59,9 mln. | Marktkapitalisatie | 108 mln. 101 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2024 * | -109 mln. -102 mln. | Nettowinst (verlies) 2025 * | -82 mln. -76,58 mln. | EV/omzet 2024 * | 4,03 x |
Nettoschuld 2024 * | 40,79 mln. 38,09 mln. | Nettoschuld 2025 * | 129 mln. 121 mln. | EV/omzet 2025 * | 3,7 x |
K/w-verhouding 2024 * |
-1,02
x | K/w-verhouding 2025 * |
-1,66
x | Werknemers | 405 |
Dividendrendement 2024 * |
-
| Dividendrendement 2025 * |
-
| Vrij verhandelbaar | 88,54% |
Recentste transcriptie over Sangamo Therapeutics, Inc.
1 dag | +2,12% | ||
1 week | +0,95% | ||
Lopende maand | -22,28% | ||
1 maand | -18,82% | ||
3 maanden | +17,90% | ||
6 maanden | +7,27% | ||
Lopend jaar | -4,12% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Alexander Macrae
CEO | Chief Executive Officer | 61 | 01-06-16 |
Director of Finance/CFO | 46 | 01-03-19 | |
Gregory Davis
CTO | Chief Tech/Sci/R&D Officer | - | 01-05-20 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Peg Horn
BRD | Director/Board Member | 61 | 15-12-22 |
James Meyers
BRD | Director/Board Member | 58 | 22-11-19 |
H. Parker
CHM | Chairman | 68 | 19-06-14 |
Naam | Gewicht | Volume | Vaira. 1 jan. | belegger rating |
---|---|---|---|---|
3.66% | 2 M€ | -25,75% | ||
0.49% | 16 M€ | -7,93% |
Datum | Koers | Variatie | Volume |
---|---|---|---|
22-04-24 | 0,5101 | -0,27% | 1 267 414 |
19-04-24 | 0,5115 | +5,44% | 1 050 146 |
18-04-24 | 0,4851 | -5,99% | 1 744 218 |
17-04-24 | 0,516 | -4,80% | 1 169 195 |
16-04-24 | 0,542 | -2,36% | 992 597 |
uitgestelde koers Nasdaq, 23 april 2024 om 22:00 uur
Meer koersenHerzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
-4,12% | 106 mln. | |
-0,49% | 103 mld. | |
+3,31% | 96,73 mld. | |
+1,66% | 21,31 mld. | |
-16,16% | 21,21 mld. | |
-6,82% | 18,79 mld. | |
-41,41% | 16,37 mld. | |
-22,87% | 13,68 mld. | |
+6,32% | 13,44 mld. | |
+21,46% | 10,98 mld. |